Ingevity CorporationNGVTNYSE
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank38
3Y CAGR-58.7%
5Y CAGR-40.8%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-58.7%/yr
vs +15.4%/yr prior
5Y CAGR
-40.8%/yr
Recent deceleration
Acceleration
-74.1pp
Decelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 1.07% |
| 2024 | -11.64% |
| 2023 | 4.95% |
| 2022 | 15.21% |
| 2021 | 16.37% |
| 2020 | 14.72% |
| 2019 | -8.37% |
| 2018 | 8.59% |
| 2017 | 160.53% |
| 2016 | 10.14% |